Alcohol consumption and digestive tract cancer

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 15, Issue 5, 2012, Pages 457-467

  Haas, Stephan L ^a   Ye, Weimin ^a   Löhr, Johannes Matthias ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ACETALDEHYDE; ALCOHOL; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; CATALASE; CYTOCHROME P450 2E1; DNA METHYLTRANSFERASE; MALONALDEHYDE; POLYAMINE; REACTIVE OXYGEN METABOLITE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; TRANSFORMING GROWTH FACTOR BETA;

ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ALCOHOLISM; BILE DUCT CANCER; CANCER RISK; CARCINOGENICITY; CHEMICAL CARCINOGENESIS; CHRONIC INFLAMMATION; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DNA ADDUCT; DNA METHYLATION; DNA MODIFICATION; DNA POLYMORPHISM; DNA REPAIR; EPIDEMIOLOGICAL DATA; EPIGENETICS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; GALLBLADDER CANCER; GENE MUTATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; LARGE INTESTINE CANCER; LARYNX CANCER; LIPID PEROXIDATION; LIVER CANCER; LIVER CELL CARCINOMA; METABOLITE; MOUTH CANCER; MUTAGENICITY; NONHUMAN; OBESITY; OXIDATIVE STRESS; PANCREAS CANCER; PATHOPHYSIOLOGY; PHARYNX CANCER; RECTUM CANCER; REVIEW; SMALL INTESTINE CANCER; SMOKING; STOMACH CANCER;

ACETALDEHYDE; ALCOHOL DRINKING; ALCOHOLISM; DNA; ETHANOL; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION; OXIDATIVE STRESS;

NICOTIANA TABACUM;

EID: 84865517340     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3283566699     Document Type: Review

References (70)

1. Boffetta P, Hashibe M. Alcohol and cancer. Lancet Oncol 2006; 7:149-156. (Pubitemid 43159501)
2. Rehm J, Baliunas D, Borges GLG, et al. The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction 2010; 105:817-843.
3. van der Wilk EA, Jansen J. Lifestyle-related risks: are trends in Europe converging? Public Health 2005; 119:55-66. (Pubitemid 39618431)
4. Raimondi S, Maisonneuve P, Löhr JM, Lowenfels AB. Early onset pancreatic cancer: evidence of a major role for smoking and genetic factors. Cancer Epidemiol Biomarkers Prev 2007; 16:1894-1897. (Pubitemid 47450523)
5. Li Y, Yang H, Cao J. Association between alcohol consumption and cancers in the Chinese population: a systematic review and meta-analysis. PLoS One 2011; 6:e18776.
6. Baan R, Straif K, Grosse Y, et al. Carcinogenicity of alcoholic beverages. Lancet Oncol 2007; 8:292-293.
7. Wu M, Zhao J-K, Zhang Z-F, et al. Smoking and alcohol drinking increased the risk of esophageal cancer among Chinese men but not women in a high-risk population. Cancer Causes Control 2011; 22:649-657.
8. Boniol M, Autier P. Prevalence of main cancer lifestyle risk factors in Europe in 2000. Eur J Cancer 2010; 46:2534-2544.
9. Druesne-Pecollo N, Tehard B, Mallet Y, et al. Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer. Lancet Oncol 2009; 10:173-180.
10. Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 2007; 7:599-612. (Pubitemid 47106631)
11. Lewis SJ, Smith GD. Alcohol, ALDH2, and esophageal cancer: a metaanalysis which illustrates the potentials and limitations of a Mendelian randomization approach. Cancer Epidemiol Biomarkers Prev 2005; 14:1967-1971. (Pubitemid 41161208)
12. Crabb DW, Matsumoto M, Chang D, You M. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc Nutr Soc 2007; 63:49-63. (Pubitemid 38543873)
13. Mathers JC, Strathdee G, Relton CL. Induction of epigenetic alterations by dietary and other environmental factors. Adv Genet 2010; 71:3-39.
14. Apte MV, Zima T, Dooley S, et al. Signal transduction in alcohol-related diseases. Alcohol Clin Exp Res 2005; 29:1299-309. (Pubitemid 41060449)
15. Seitz HK, Stickel F. Acetaldehyde as an underestimated risk factor for cancer development: role of genetics in ethanol metabolism. Genes Nutr 2009. [Epub ahead of print]
16. Bartsch H, Nair J. Accumulation of lipid peroxidation-derived DNA lesions: potential lead markers for chemoprevention of inflammation-driven malignancies. Mutat Res 2005; 591:34-44. (Pubitemid 41654838)
17. Das SK, Vasudevan DM. Alcohol-induced oxidative stress. Life Sci 2007; 81:177-187. (Pubitemid 46978376)
18. Zakhari S. Overview: how is alcohol metabolized by the body? Alcohol Res Health 2006; 29:245-254.
19. Brooks PJ, Theruvathu JA. DNA adducts from acetaldehyde: implications for alcohol-related carcinogenesis. Alcohol 2005; 35:187-193. (Pubitemid 41079922)
20. Theruvathu JA, Jaruga P, Nath RG, et al. Polyamines stimulate the formation of mutagenic 1,N2-propanodeoxyguanosine adducts from acetaldehyde. Nucleic Acids Res 2005; 33:3513-3520. (Pubitemid 41430574)
21. Wang H, Kozekov ID, Kozekova A, et al. Site-specific synthesis of oligonucleotides containing malondialdehyde adducts of deoxyguanosine and deoxyadenosine via a postsynthetic modification strategy. Chem Res Toxicol 2006; 19:1467-1474. (Pubitemid 44863489)
22. Kurkivuori J, Salaspuro V, Kaihovaara P, et al. Acetaldehyde production from ethanol by oral streptococci. Oral Oncol 2007; 43:181-186. (Pubitemid 46176706)
23. Nieminen MT, Uittamo J, Salaspuro M, Rautemaa R. Acetaldehyde production from ethanol and glucose by non-Candida albicans yeasts in vitro. Oral Oncol 2009; 45:e245-e248.
24. Gu J-W, Bailey AP, Sartin A, et al. Ethanol stimulates tumor progression and expression of vascular endothelial growth factor in chick embryos. Cancer 2005; 103:422-431. (Pubitemid 40129304)
25. Teyssen S, Gonzalez-Calero G, Schimiczek M, Singer MV. Maleic acid and succinic acid in fermented alcoholic beverages are the stimulants of gastric acid secretion. J Clin Invest 1999; 103:707-713. (Pubitemid 29122424)
26. Siegmund SV, Singer MV. Effects of alcohol on the upper gastrointestinal tract and the pancreas-an up-to-date overview. Z Gastroenterol 2005; 43:723-736. (Pubitemid 41233460)
27. Botterweck AA, Schouten LJ, Volovics A, et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000; 29:645-654. (Pubitemid 30612230)
28. Corley DA, Buffler PA. Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the cancer incidence in five continents database. Int J Epidemiol 2001; 30:1415-1425. (Pubitemid 34134300)
29. Alcohol drinking. IARC Working Group, Lyon, 13-20 October 1987. IARC Monogr Eval Carcinog Risks Hum 1988; 44:1-378.
30. Secretan B, Straif K, Baan R, et al. A review of human carcinogens: Part E - tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009; 10:1033-1034.
31. Tramacere I, Pelucchi C, Bagnardi V, et al. A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk. Ann Oncol 2012; 23:287-297.
32. Erichsen R, Robertson D, Farkas DK, et al. Erosive reflux disease increases risk for esophageal adenocarcinoma, compared with nonerosive reflux. Clin Gastroenterol Hepatol 2012; 10:475-480.
33. Steevens J, Schouten LJ, Driessen ALC, et al. A prospective cohort study on overweight, smoking, alcohol consumption, and risk of Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2011; 20:345-358.
34. Pandeya N, Williams G, Green AC, et al. Australian Cancer Study. Alcohol consumption and the risks of adenocarcinoma and squamous cell carcinoma of the esophagus. Gastroenterology 2009; 136:1215-1224. e1-e2.
35. Oze I, Matsuo K, Ito H, et al. Cigarette smoking and esophageal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2012; 42:63-73.
36. Islami F, Fedirko V, Tramacere I, et al. Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: a systematic review and meta-analysis. Int J Cancer 2011; 129:2473-2484.
37. Gao G-F, Roth MJ, Wei W-Q, et al. No association between HPV infection and the neoplastic progression of esophageal squamous cell carcinoma: result from a cross-sectional study in a high-risk region of China. Int J Cancer 2006; 119:1354-1359. (Pubitemid 44258811)
38. Ferlay J, Shin H-R, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893-2917.
39. IARC monographs on the evaluation of carcinogenic risks to humans /World Health Organization, International Agency for Research on Cancer. IARC Monogr Eval Carcinog Risks Hum 1988; 44:1-378.
40. Tramacere I, Negri E, Pelucchi C, et al. A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol 2012; 23:28-36.
41. Moy KA, Fan Y, Wang R, et al. Alcohol and tobacco use in relation to gastric cancer: a prospective study of men in Shanghai, China. Cancer Epidemiol Biomarkers Prev 2010; 19:2287-2297.
42. Duell EJ, Travier N, Lujan-Barroso L, et al. Alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Am J Clin Nutr 2011; 94:1266-1275.
43. Shin CM, Kim N, Cho S-I, et al. Association between alcohol intake and risk for gastric cancer with regard to ALDH2 genotype in the Korean population. Int J Epidemiol 2011; 40:1047-1055.
44. Ferronha I, Bastos A, Lunet N. Prediagnosis lifestyle exposures and survival of patients with gastric cancer: systematic review and meta-analysis. Eur J Cancer Prev 2012. [Epub ahead of print]
45. Franceschi S, La Vecchia C. Alcohol and the risk of cancers of the stomach and colon-rectum. Dig Dis 1994; 12:276-289.
46. Bongaerts BWC, van den Brandt PA, Goldbohm RA, et al. Alcohol consumption, type of alcoholic beverage and risk of colorectal cancer at specific subsites. Int J Cancer 2008; 123:2411-2417.
47. Cho E, Lee JE, Rimm EB, et al. Alcohol consumption and the risk of colon cancer by family history of colorectal cancer. Am J Clin Nutr 2012; 95:413-419.
48. Setshedi M, Wands JR, Monte SM de L. Acetaldehyde adducts in alcoholic liver disease. Oxid Med Cell Longev 2010; 3:178-185.
49. Voigt MD. Alcohol in hepatocellular cancer. Clin Liver Dis 2005; 9:151-169. (Pubitemid 40341951)
50. Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology 2004; 127 (5 Suppl 1):S87-S96. (Pubitemid 39423374)
51. Shimazu T, Sasazuki S, Wakai K, et al. Alcohol drinking and primary liver cancer: a pooled analysis of four Japanese cohort studies. Int J Cancer 2012; 130:2645-2653.
52. Saieva C, Bardazzi G, Masala G, et al. General and cancer mortality in a large cohort of Italian alcoholics. Alcohol Clin Exp Res 2012; 36:342-350.
53. Okuda K. Hepatocellular carcinoma. J Hepatol 2000; 32 (1 Suppl):225- 237. (Pubitemid 30123637)
54. Heintges T, Wands JR. Hepatitis C virus: epidemiology and transmission. Hepatology 1997; 26:521-526. (Pubitemid 27392339)
55. Yuan J-M, Govindarajan S, Arakawa K, Yu MC. Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. Cancer 2004; 101:1009-1017. (Pubitemid 39100435)
56. Machida K, Tsukamoto H, Mkrtchyan H, et al. Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog. Proc Natl Acad Sci USA 2009; 106:1548-1553.
57. Tsukamoto H, Zhu N-L, Wang J, et al. Morphogens and hepatic stellate cell fate regulation in chronic liver disease. J Gastroenterol Hepatol 2012; 27 (Suppl 2):94-98.
58. Reddy SK, Steel JL, Chen H-W, et al. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease. Hepatology 2012; 55:1809-1819.
59. Heckley GA, Jarl J, Asamoah BO, G-Gerdtham U. How the risk of liver cancer changes after alcohol cessation: a review and meta-analysis of the current literature. BMC Cancer 2011; 11:446.
60. Egyed-Zsigmond I, Jung I, Egyed-Zsigmond I, et al. Immunohistochemical comparative study of fibrosis and biliary ductular rreaction in alcoholic and viral chronic hepatitis. Rom J Morphol Embryol 2010; 51:265-269.
61. Thygesen LC, Mikkelsen P, Andersen TV, et al. Cancer incidence among patients with alcohol use disorders: long-term follow-up. Alcohol Alcohol 2009; 44:387-391.
62. Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepatology 2011; 54:173-184.
63. Bulajic M, Maisonneuve P, Schneider-Brachert W, et al. Helicobacter pylori and the risk of benign and malignant biliary tract disease. Cancer 2002; 95:1946-1953. (Pubitemid 35222175)
64. Tao L-Y, He X-D, Qu Q, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China. Liver Int 2010; 30:215-221.
65. Wu T-T, Levy M, Correa AM, et al. Biliary intraepithelial neoplasia in patients without chronic biliary disease. Cancer 2009; 115:4564-4575.
66. Grainge MJ, West J, Solaymani-Dodaran M, et al. The antecedents of biliary cancer: a primary care case-control study in the United Kingdom. Br J Cancer 2009; 100:178-180.
67. Ye W, Lagergren J, Weiderpass E, et al. Alcohol abuse and the risk of pancreatic cancer. Gut 2002; 51:236-239. (Pubitemid 34791453)
68. Rohrmann S, Linseisen J, Vrieling A, et al. Ethanol intake and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition (EPIC). Cancer Causes Control 2009; 20:785-794.
69. Gapstur SM, Jacobs EJ, DeKa A, et al. Association of Alcohol intake with pancreatic cancer mortality in never smokers. Arch Intern Med 2011; 171:444-451.
70. Johansen D, Borgstr Ouml MA, Lindkvist BOR, Manjer J. Different markers of alcohol consumption, smoking and body mass index in relation to risk of pancreatic cancer. Pancreatology 2009; 9:677-686.